Granulomatous Rosacea- Like Reaction During Dupilumab Treatment

Dermatitis. 2024 May-Jun;35(3):308-310. doi: 10.1089/derm.2023.0126. Epub 2023 Jul 11.

Authors

Francesca Falcinelli¹, Laura Lazzeri², Noemi La Francesca³, Ester Sorrentino³, Martina Dragotto², Vittoria Cioppa², Pietro Rubegni², Filomena Russo²

Affiliations

¹ Dermatology Unit, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy. f.falcinelli@student.unisi.it.
² Dermatology Unit, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
³ Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy.

PMID: 37432781
DOI: 10.1089/derm.2023.0126

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Female
Granuloma / chemically induced
Granuloma / pathology
Humans
Male
Middle Aged
Rosacea* / chemically induced
Rosacea* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized